risks of semaglutide injections The Therapeutic Goods Administration has issued an urgent safety warning over the risk suicidal thoughts linked to popular drugs used to treat type 2 diabetes and obesity. The affected drugs include While many patients are seeing

The ophthalmic system, in many ways, serves as an extension of the brain

By Route of Administration: Parenteral dominates, Oral growing fastest Parenteral (subcutaneous injection) delivery held the dominant route of administration position in 2025, reflecting that all high-dose, high-efficacy GLP-1 formulations currently approved for obesity management require injection for the delivery of drug quantities sufficient to achieve therapeutic plasma concentrations

Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function

Sci Transl Med 2024;16:eadk4908.ArticlePubMed 77